Nat Metab | genome-wide CRISPR screening found that type I diabetes new therapeutic targets—RNLS
Nat Metab | genome-wide CRISPR screening found that type I diabetes new therapeutic targets—RNLS
[unable to retrieve full-text content]
Type I diabetes is an autoimmune disease,many at a young age of onset,so it is also called juvenile diabetes. Type I diabetes onset the cause is itself of some T cells begin to recognize and attack its own islet cells,eventually almost all of the islet…
Baidu snapshot
Published at Mon, 03 Aug 2020 22:46:04 +0000